Clinical Trials Directory

Trials / Completed

CompletedNCT04220099

Electroencephalogram (EEG) and Electroconvulsive Therapy(ECT) Response in Schizophrenia

Pretreatment Electroencephalogram (EEG) May Predict Electroconvulsive Therapy(ECT) Effect in Schizophrenia

Status
Completed
Phase
Study type
Observational
Enrollment
30 (actual)
Sponsor
Shanghai Mental Health Center · Academic / Other
Sex
All
Age
18 Years – 60 Years
Healthy volunteers
Not accepted

Summary

This study is designed to find quantitative Electroencephalogram(qEEG) biomarkers to predict Electroconvulsive Therapy(ECT) Response in Schizophrenia

Detailed description

The purpose of this proposal is to explore quantitative Electroencephalogram(qEEG) biomarkers that would predict Electroconvulsive Therapy(ECT) Response in Schizophrenia (SZD). The investigators will recruit 30 SZD patients who are preparing for ECT treatment and assesse psychotic symptoms using Positive and Negative symptom scale(PANSS) before and after 8-sessions clinical course of ECT treatment. These patients needed ECT treatment are assessed by clinicians according to American Psychiatric Association(APA) guidelines. Meanwhile resting EEG will be recorded for 10 minutes before the first episode of ECT treatment. Decrease of PANSS scores will be calculated after the last session of ECT treatment to distinguish responder/non-responder.

Conditions

Interventions

TypeNameDescription
PROCEDUREElectroconvulsive therapy(ECT)Patients recieve 8-sessions ECT treatments and those kinds of drugs they take since they were recruited remain unchanged during this study.

Timeline

Start date
2020-01-07
Primary completion
2020-06-05
Completion
2020-07-04
First posted
2020-01-07
Last updated
2020-07-07

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT04220099. Inclusion in this directory is not an endorsement.